A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations

A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations

Tetracycline-based matrix metalloproteinase- (MMP-) inhibitors are currently approved for two inflammatory diseases, periodontitis and rosacea. The current study addresses the therapeutic potential of a novel pleiotropic MMP-inhibitor not based on an antibiotic. To induce experimental periodontitis,...

Full description

Saved in:
Bibliographic Details
Main Authors: Muna S. Elburki, Carlos Rossa, Morgana R. Guimaraes, Mark Goodenough, Hsi-Ming Lee, Fabiana A. Curylofo, Yu Zhang, Francis Johnson, Lorne M. Golub
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2014/959471
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items